QuidelOrtho Corporation (QDEL) financial statements and ratios from SEC XBRL: revenue $2.7B (TTM), net margin -41.5%, revenue growth 2.8% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $2.73B |
| Revenue (TTM) | $2.7B |
| Net Margin | -41.5% |
| Operating Margin (TTM) | -30.8% |
| Net Debt / EBITDA | -0.6 |
| Revenue Growth (YoY) | 2.8% |
| EPS Growth (YoY) | -63.9% |
| FCF Growth (YoY) | 171.2% |
| Price / Book | 0.54 |
| Price / Sales | 0.36 |
| FCF Yield | -8.7% |
| Altman Z-Score | -0.10 (distress) |
| Industry P/E (Pharmaceutical Products) | 17.1 |
| Sector P/E (Healthcare) | 21.6 |
QDEL overview · QDEL earnings · QDEL KPIs · QDEL documents · QDEL ownership · QDEL peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.